期刊文献+

肝内及肝外胆管癌组织表达上调microRNAs表达谱的鉴定 被引量:5

Identification of up-regulated miRNAs in extrahepatic and intrahepatic cholangiocarcinoma
原文传递
导出
摘要 目的筛选、鉴定肝内及肝外胆管癌组织表达上调的miRNAs,并探讨其在胆管癌细胞增殖中的作用。方法利用miRNA-基因芯片方法筛选肝内、肝外胆管癌组织特异表达上调或共同表达上调的miRNAs;利用实时PCR方法对其进行验证;选择特异miRNA抑制剂转染胆管癌细胞系QBC939并利用MTT检测方法,对上述表达上调明显的miRNAs进行初步的功能研究,探讨miRNAs表达上调与胆管细胞癌细胞增殖的关系。结果12个miRNAs在肝外及肝内胆管癌组织共同表达上调,肝外胆管癌组织特异表达上调的miRNAs有28个,其中miR-125b与miR-19a分别表达上调3.7倍与3.6倍(P〈0.05);肝内胆管癌有12个miRNAs特异表达上调,其中miR-92a与miR-205分别表达上调约4.5倍与3.5倍(P〈0.05);在胆管癌细胞系QBC939中抑制miR-125b、miR-19a、miR-21以及miR-378’的内源性表达,可以明显抑制QBC939细胞的增殖,其抑制效率分别为71%、72%、69%与76%(P〈0.05,36h),61%、63%、60%与59%(P〈0.01,48h),61%、56%、60%与59%(P〈0.05,60h)。结论肝内及肝外胆管癌具有不同的miRNAs上调表达谱,敲低表达上调的miRNAs可以明显抑制胆管癌细胞增殖。 Objective To investigate the expression profile of miRNAs up-regualted in human extrahepatic and intrahepatic cholangiocarcinoma tissues and probe the effect on cell growth of four of these miRNAs in QBC939 cell line. Methods Up-regulated miRNAs in extrahepatic or intrahepatic cholangiocarcinoma tissues were analyzed by using miRNA-microarray, which was confirmed by using miRNA Real-Time PCR analysis. Based on these findings, four of these up-regulated miNRAs were chosen to perform function investigation. The specific miRNA inhibitors were transfected into QBC939 cells, respectively, and cell proliferation assay was performed by using MTT. Results 12 miRNAs were up-regulated both in two types of cholangioeareinoma tissues, 28 miRNAs and 21 miRNAs were up-regulated in extrahepatie eholangioeareinoma and intrahepatic cholangioearcinoma, respectively. MiR-125b and miR-19a expression levels were increased about 3.7- and 3.6-fold, compared with the matched normal bile duct tissues (P〈0.05). MiR-92a and miR-205 expression was upregulated about 4.5- and 3.5-fold, compared with the matched normal bile duct tissues (P〈0.05). MiR-125b, miR- 19a, miR-21, and miR-378* were inhibited in QBC939 cells, which indicated a significant inhibitory effect on cell growth. The ratio of inhibition was 71%, 72%, 69%, and 76% (P〈0.05)at a6 h, 61%, 63%, 60%, and 59M(P〈0. 01) at 48 h, and 61%,56%,60% and 59z%(P〈0.05) at 60 h. Conclusion The miRNAs expression patterns in human extrahepatic and intrahepatic cholangiocarci- noma tissues are different and up-regulated miRNAs act as oncomirs on cholangiocarcinoma cell growth.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第6期466-469,共4页 Chinese Journal of Hepatobiliary Surgery
基金 本课题受国家自然科学基金青年基金资助(基金编号81100608)
关键词 肝外胆管癌 肝内胆管癌 microRNA 细胞增殖 Extrahepatic cholangiocareinomal Intrahepatic cholangiocarcinoma MicroRNAs Cell growth
  • 相关文献

参考文献11

  • 1Ambros V. microRNAs: tiny regulators with great potential [J]. Cell, 2001, 107: 823-826. 被引量:1
  • 2Lee RC, Feinbaum RL, Ambros V. The C. elegans hetero- chronic gene lin-4 encodes small RNAs with antisense comple mentarity to lin 14[J]. Cell, 1993, 75: 843-854. 被引量:1
  • 3Liu C, Yu J, Yu S, et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma [J]. J Hepatol, 2010, 53:98-107. 被引量:1
  • 4Lu J, Getz G, Miska EA, et al. MieroRNA expression profiles classify human cancers[J]. Nature, 2005, 435 (7043) : 834-838. 被引量:1
  • 5Friman S. Cholangiocarcinoma-current treatment options[J]. Scand J Surg, 2011, 100: 30-34. 被引量:1
  • 6郭婧,李基业.胆管癌分子病理学研究进展[J].中华肝胆外科杂志,2011,17(2):171-174. 被引量:5
  • 7王茂生,崔平,李继梅,贾伟,陈圣雄.干扰XIAP基因联合5-FU对人胆管癌细胞体内生长抑制的实验研究[J].中华肝胆外科杂志,2011,17(7):591-592. 被引量:1
  • 8方福德主编,王芳等编..microRNA的研究方法与应用[M].北京:中国协和医科大学出版社,2008:246.
  • 9Perrotti D, Eiring AM. The new role of microRNAs in cancer [J]. Future Oncol, 2010, 6:1203-1206. 被引量:1
  • 10Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model[J]. Cell, 2009, 137:1005-1017. 被引量:1

二级参考文献13

共引文献4

同被引文献53

  • 1苗丽君,王静.Akt与肿瘤的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(5):406-409. 被引量:38
  • 2Shaib YH, E1-Serag HB, Davila JA, et al. Risk factors of in- trahepatic cholangiocarcinoma in the United States a case- control study[J]. Gastroenterology, 2005,128 : 620-626. 被引量:1
  • 3Shaib YH, Davila JA, Mcglynn K, ct al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? [J]. J Hepatol,2004,40:472-477. 被引量:1
  • 4Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarci- noma[J]. Lancet, 2005,366 :1303-1314. 被引量:1
  • 5Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangio- careinoma[J]. Surg Clin North Am, 2010,90:817-837. 被引量:1
  • 6Ryan BM, Robles AI, Harris CC. Genetic variation in mi- croRNA networks: the imp[ications for cancer researeh[J]. Nat Rev Cancer, 2010,10:389-402. 被引量:1
  • 7Gentilin E, Tagliati F, Filieri C, et al. miR-26a plays an im- portant role in cell cycle regulation in ACTH-secreting pituita- ry adenomas by modulating protein kinase Cdelta [J ]. Endocrinology, 2013,154 : 1690-1700. 被引量:1
  • 8Yu L, Lu J, Zhang B, et al. miR-26a inhibits invasion and me- tastasis of nasopharyngea! cancer by targeting EZH2 [J]. Oncol Lett, 2013,5 : 1223-1228. 被引量:1
  • 9Gao J, Li L, Wu M, et al. MiR-26a Inhibits proliferation and migration of breast cancer through repression of MCL-I[J].PLoS One, 2013,8:e65138. 被引量:1
  • 10Liu B, Wu X, Liu B, et al. MiR-26a enhances metastasis po tential of lung cancer cells via AKT pathway by targeting PTEN[J]. Biochim Biophys Acta, 2012,1822 : 1692-1704. 被引量:1

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部